ClinicalTrials.gg
Not yet recruitingNCT07750418TLIP-QIPUpdated Aug 6, 2026

Comparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surgery

An observational study in Lumbar Disc Herniation and Postoperative Pain, sponsored by Vezirköprü State Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Vezirköprü State Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study compares two regional anesthesia techniques used for pain control after lumbar spine surgery: the classic thoracolumbar interfascial plane (TLIP) block and the quadratus lumborum-iliac plane (QIP) block. Patients between 18 and 65 years of age who undergo elective lumbar discectomy (up to two spinal levels) will be observed based on which block their treating anesthesiologist chooses to use as part of routine clinical practice. No randomization or additional intervention beyond standard care will be performed. Researchers will record the total amount of opioid pain medication used in the first 24 hours after surgery, the time until the first request for pain medication, pain scores at several time points after surgery (0, 1, 2, 4, 8, 12, and 24 hours), and any side effects (such as nausea, vomiting, or sedation) or complications related to the block. The aim is to compare the effectiveness and safety of these two techniques in reducing pain and opioid use after lumbar spine surgery.

Read the detailed description

Patients undergoing elective lumbar discectomy at up to two levels, ASA physical status I-II, aged 18-65 years, who receive either a classic TLIP block or a QIP block as part of routine clinical anesthesia practice will be included in this prospective observational study. The choice of block technique is determined solely by the treating anesthesiologist's routine practice, not by study allocation. Both blocks are performed under ultrasound guidance at the end of surgery, before emergence from anesthesia, using bilateral injections of 20 mL (40 mL total) of 0.25% bupivacaine. All patients receive standardized general anesthesia and a multimodal analgesic regimen (intravenous paracetamol, dexketoprofen, and tramadol as rescue analgesia for VAS ≥ 4). Outcomes recorded include total opioid consumption in the first 24 postoperative hours, time to first opioid request, VAS pain scores at PACU (0h), 1, 2, 4, 8, 12, and 24 hours, postoperative side effects (nausea, vomiting, pruritus, sedation, hypotension), and block-related complications (hematoma, local anesthetic systemic toxicity, infection).

02

Conditions studied

  • Lumbar Disc Herniation
  • Postoperative Pain

Keywords

  • Thoracolumbar Interfascial Plane Block
  • Quadratus Lumborum Block
  • Lumbar Discectomy
  • Postoperative Analgesia
03

In context

Intervertebral Disc Displacement

474 studies on the registry are indexed under Intervertebral Disc Displacement; 100 are open to participants now.

This study's planned enrollment of 60 is below the median of 100 across 117 observational studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

Vezirköprü State Hospital is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 18-65 years, ASA physical status I-II, undergoing elective lumbar discectomy at up to two spinal levels under general anesthesia at Vezirköprü State Hospital, who receive either a classic TLIP block or a QIP block for postoperative analgesia as part of routine clinical practice.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-65 years
  • I-II
  • Undergoing elective lumbar discectomy at up to two spinal levels under general anesthesia
  • Receiving classic TLIP block or QIP block for postoperative analgesia as part of routine clinical practice

Exclusion criteria

Exclusion Criteria:

  • or allergy to study medications
  • Coagulopathy
  • Infection at the injection site
  • Severe neurological deficit
  • Chronic opioid use
  • Advanced hepatic or renal failure
  • Obesity ( >35 kg/m2)
  • Pregnancy
  • III-IV
  • Mental retardation
  • Inability to provide
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • TLIP Block

    Patients who receive a classic thoracolumbar interfascial plane (TLIP) block for postoperative analgesia after lumbar discectomy, as determined by the treating anesthesiologist's routine clinical practice. The block is performed under ultrasound guidance in the fascial plane between the multifidus and longissimus muscles, using bilateral injections of 20 mL (40 mL total) of 0.25% bupivacaine

    Procedure: Thoracolumbar Interfascial Plane (TLIP) Block of bupivacaine

  • QIP Block

    Patients who receive a quadratus lumborum-iliac plane (QIP) block for postoperative analgesia after lumbar discectomy, as determined by the treating anesthesiologist's routine clinical practice. The block is performed under ultrasound guidance in the interfascial plane between the erector spinae and quadratus lumborum muscles at the iliac crest level, using bilateral injections of 20 mL (40 mL total) of 0.25% bupivacaine.

    Procedure: Quadratus Lumborum-Iliac Plane (QIP) Block

Interventions

  • ProcedureThoracolumbar Interfascial Plane (TLIP) Block of bupivacaine

    Ultrasound-guided injection of 20 mL bilaterally (40 mL total) of 0.25% bupivacaine into the fascial plane between the multifidus and longissimus muscles at the relevant lumbar level, performed at the end of surgery before emergence from anesthesia, as part of routine postoperative analgesia.

    Also known as: TLIP Block

  • ProcedureQuadratus Lumborum-Iliac Plane (QIP) Block

    Ultrasound-guided injection of 20 mL bilaterally (40 mL total) of 0.25% bupivacaine into the interfascial plane between the erector spinae and quadratus lumborum muscles at the iliac crest level, performed at the end of surgery before emergence from anesthesia, as part of routine postoperative analgesia.

    Also known as: QIP Block

06

What researchers measure

Primary outcomes

  1. Total Opioid Consumption in the First 24 Postoperative Hours

    Cumulative amount of intravenous tramadol (mg) administered as rescue analgesia during the first 24 hours after surgery in each group.

    Time frame: 0 to 24 hours after surgery

Secondary outcomes

  1. Time to First Opioid Request

    Time elapsed from end of surgery to the first patient request for rescue opioid analgesia (VAS ≥ 4)

    Time frame: Up to 24 hours after surgery

  2. Postoperative Pain Score (Visual Analog Scale)

    Pain intensity measured using the Visual Analog Scale (VAS, 0 = no pain, 10 = worst imaginable pain) at PACU (0h) and at 1, 2, 4, 8, 12, and 24 hours after surgery.

    Time frame: 0, 1, 2, 4, 8, 12, and 24 hours after surgery

  3. Incidence of Postoperative Side Effects

    Number of patients experiencing nausea, vomiting, pruritus, sedation, or hypotension after surgery.

    Time frame: Up to 24 hours after surgery

  4. Incidence of Block-Related Complications

    Number of patients experiencing hematoma, local anesthetic systemic toxicity, or infection related to the block procedure.

    Time frame: Up to 24 hours after surgery

07

Study locations

1 site
  • Vezirköprü State Hospital
    Vezirköprü, Samsun, Turkey (Türkiye)
    • MEHMET YUSUF YILMAZ, MD · Contactmyyilmaz55@gmail.com · +90 537 816 24 87
    • BETUL YILMAZ, MD · Contactbetuluslucan@gmail.com · +90 505 035 64 70
    • MEHMET YUSUF YILMAZ, MD · Principal investigator
    • BETUL YILMAZ, MD · Sub investigator
    • BETUL MALKOC, MD · Sub investigator
    • EMINE OZDEMIR, MD · Sub investigator
    • OZGUR DOKMECI, MD · Sub investigator
08

References and documents

Publications

  • Tulgar S, Ciftci B, Ahiskalioglu A, Bilal B, Sakul BU, Girit M, Akin T, Narayanan M, Alici HA. Ultrasound guided quadro-iliac plane block: another novel fascial plane block. Pain Med. 2024 May 3;25(6):370-373. doi: 10.1093/pm/pnae018. PubMed 38459608 ↗
  • Hand WR, Taylor JM, Harvey NR, Epperson TI, Gunselman RJ, Bolin ED, Whiteley J. Thoracolumbar interfascial plane (TLIP) block: a pilot study in volunteers. Can J Anaesth. 2015 Nov;62(11):1196-200. doi: 10.1007/s12630-015-0431-y. Epub 2015 Jul 7. PubMed 26149600 ↗
  • Yeung J, Small C. Impact of regional analgesia in surgery. Br J Surg. 2021 Sep 27;108(9):1009-1010. doi: 10.1093/bjs/znab214. No abstract available. PubMed 34131701 ↗
  • Andreae MH, Andreae DA. Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis. Br J Anaesth. 2013 Nov;111(5):711-20. doi: 10.1093/bja/aet213. Epub 2013 Jun 28. PubMed 23811426 ↗
  • Humble SR, Dalton AJ, Li L. A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain. 2015 Apr;19(4):451-65. doi: 10.1002/ejp.567. Epub 2014 Aug 4. PubMed 25088289 ↗
  • Dietz N, Sharma M, Adams S, Alhourani A, Ugiliweneza B, Wang D, Nuno M, Drazin D, Boakye M. Enhanced Recovery After Surgery (ERAS) for Spine Surgery: A Systematic Review. World Neurosurg. 2019 Oct;130:415-426. doi: 10.1016/j.wneu.2019.06.181. Epub 2019 Jul 2. PubMed 31276851 ↗
  • Bajwa SJ, Haldar R. Pain management following spinal surgeries: An appraisal of the available options. J Craniovertebr Junction Spine. 2015 Jul-Sep;6(3):105-10. doi: 10.4103/0974-8237.161589. PubMed 26288544 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Dec 2026, 4 months later.

Of 45 non-industry observational studies under Intervertebral Disc Displacement, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 69. This study's planned 4 months is below that.

Counting every sponsor, half of 49 studies reached it within 35 months; a quarter within 13 and three quarters within 82.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 1, 2026
First posted
Aug 6, 2026
StartEst.
Aug 15, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07750418
Lead sponsor
Vezirköprü State Hospital
Responsible party
Sponsor
First posted
Aug 6, 2026
Start date
Aug 15, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 6, 2026

Study contacts

MEHMET YUSUF YILMAZ, MD
Contact
myyilmaz55@gmail.com
+90 537 816 24 87
BETUL YILMAZ, MD
Contact
betuluslucan@gmail.com
+90 505 035 64 70
MEHMET YUSUF YILMAZ, MD
principal investigator · Vezirkopru State Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion